Updated results from the completed Phase 1 study of etavopivat in patients with sickle cell disease (SCD) Study design for the Phase 2 Gladiolus Study of etavopivat in patients with transfusion-dependent
Investegate announcements from Global Blood Therapeutics, Inc, GBT Presents Positive New Real-World Evidence Data at EHA2022 Congress Further Supporting Clinical Use of Oxbryta® (voxelotor) in Sickle Cell Disease
/PRNewswire/ In medical news, Functional Fluidics today announces that abstracts related to their red blood cell biomarker used in sickle cell disease.
/PRNewswire/ MACADOO today announced that it has been named national agency of record across multiple marketing services disciplines by Foundation for.
PR News | Accounts in Transit: MikeWorldWide Orders Marco s Pizza odwyerpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from odwyerpr.com Daily Mail and Mail on Sunday newspapers.